:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Author:	Josef Finsterer
Format:	Recurso digital
Language:
Published:	Zenodo 2024
Online Access:	https://doi.org/10.5281/zenodo.13367747
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Post‐COVID dysphagia requires exclusion of SARS‐CoV‐2–associated brainstem encephalitis, vasculitis, polyneuritis cranialis, and myositis
by: Josef Finsterer
Published: (2024)

An improvement of the safety profile of SARS‐CoV‐2 vaccines is desirable
by: Josef Finsterer
Published: (2024)

Whether the Opsoclonus Myoclonus Syndrome Is Paraneoplastic or SARS‐CoV‐2–Related Can Be Clarified
by: Josef Finsterer
Published: (2025)

Chronic Local Pain, Especially Headaches, May Not Be the Only Cause of Depression
by: Josef Finsterer
Published: (2025)

Before Permanent Hemifacial Pain can be attributed to SARS-CoV-2, Alternative Etiologies must be Ruled Out
by: Walter Strobl, et al.
Published: (2023)

The Loss and Dysfunction of Smooth Muscle Cells in MELAS Are Not the Only Cause for Gastrointestinal Dysmotility
by: Josef Finsterer
Published: (2026)

Plasmodium Vivax Can Only Be Responsible for GBS if All Other Triggers Have Been Ruled Out
by: Josef Finsterer
Published: (2026)

Leigh Syndrome Due to the Variant c. 1019T >C in COX15
by: Josef Finsterer
Published: (2025)

Homogeneous ALS Cohorts in Terms of Etiology, onset type, and Vaccination Status Are Required to Assess the Outcome of Their COVID Infection
by: Josef Finsterer
Published: (2025)

Polymyalgia Rheumatica Post-SARS-CoV-2 Infection
by: Carolina Duarte-Salazar, et al.
Published: (2024)

COVID‐19 Patients With Neurological Symptoms Require a Neurological Diagnosis and the Establishment of a Causal Relationship
by: Josef Finsterer
Published: (2025)

The Effectiveness of COVID‐19 Vaccination on Post‐Acute Sequelae of SARS‐CoV‐2 Infection Among Geriatric Patients
by: Yi‐Ju Chan, et al.
Published: (2024)

COVID-19 y SARS-CoV-2
by: Alfredo Pinzón-Junca
Published: (2020)

Prevalence, pathogenesis and spectrum of neurological symptoms in COVID‐19 and post‐COVID‐19 syndrome
by: Josef Finsterer, et al.
Published: (2024)

Death of a Child With Celiac Disease and Cerebral Bleeding Requires Extensive Post‐Mortem Analysis to Clarify the Underlying Pathophysiology
by: Josef Finsterer
Published: (2025)

Current Topics in SARS-CoV-2/COVID-19
Published: (2023)

The discovery, origins and evolution of SARS-CoV-2 (COVID-19)
by: Holmes, Edward C
Published: (2021)

SARS‐CoV‐2 nucleocapsid antigen in plasma of children hospitalized for COVID‐19 or with incidental detection of SARS‐CoV‐2 infection
by: Nicolas Capelli, et al.
Published: (2024)

Alterations in Cellular Gene Expression Due to Co‐Infection With Kaposi's Sarcoma‐Associated Herpesvirus and SARS‐CoV‐2: Implications for Disease Severity
by: Jungang Chen, et al.
Published: (2024)

Long‐Term Sequelae of COVID‐19: A Systematic Review and Meta‐Analysis of Symptoms 3 Years Post‐SARS‐CoV‐2 Infection
by: Masoud Rahmati, et al.
Published: (2025)

SARS‐CoV‐2 targets mitochondria, exacerbating COVID‐19 pneumonia
by: Danchen Wu, et al.
Published: (2026)

Taming the Cytokine Storm: Therapeutic Strategies for Post‐Acute Sequelae of SARS‐CoV‐2 Infection
by: Emmanuel Ifeanyi Obeagu
Published: (2026)

Association Between Influenza Vaccination and SARS‐CoV‐2 Infection
by: Marwan Ma'ayeh, et al.
Published: (2024)

Use of Azithromycin Attributable to Acute SARS‐CoV‐2 Infection
by: Carlo Gagliotti, et al.
Published: (2024)

SARS-CoV-2: structure, replication and pathophysiological mechanisms related to COVID-19
by: Arandia Guzmán Jaime
Published: (2020)

Because secondary intestinal pseudo‐obstruction is potentially treatable, its etiology needs to be clarified
by: Josef Finsterer
Published: (2024)

Mitochondrial diabetes plus phenotypes due to the m.3243A > G variant require correlation with heteroplasmy rates
by: Josef Finsterer
Published: (2024)

Sulfasalazine, but not ankylosing spondylitis may be responsible for axonal neuropathy
by: Josef Finsterer
Published: (2024)

Brain Pathology in m.3243A>G Carriers
by: Josef Finsterer
Published: (2023)

Treatment of Stroke-Like Episodes Requires NO-Precursors, Avoidance of Mitochondrion Toxic Drugs, and Antiepileptics only When Seizures Occur
by: Josef Finsterer
Published: (2025)

Contiguous Xp21 Deletion Syndrome with Atypical Phenotype Requires Further Clarification Using WES
by: Josef Finsterer
Published: (2025)

Less Social Contact During the Pandemic Could Explain the Lower Prevalence of GBS During This Time
by: Josef Finsterer
Published: (2025)

Muscle Membrane Permeability Determined by 31P‐MRS and DT‐MRI as a Biomarker for the Progression of Becker Muscular Dystrophy
by: Josef Finsterer
Published: (2026)

In Reference to Bilateral Sudden or Chronic Hearing Loss as an Auditory Manifestation of Mitochondrial DNA Mutations
by: Josef Finsterer
Published: (2025)

The Spectrum of Risk Factors for Falls is Broader Than Expected
by: Josef Finsterer
Published: (2025)

Commentary on: Sağlam İ, Aslan R, Akgür SA, Kurtulmuş Y. Abuse of gabapentinoids in individuals with substance use disorders. J Forensic Sci. 2025;70(3):1125–32. doi: 10.1111/1556‐4029.70028
by: Josef Finsterer
Published: (2025)

Pembrolizumab‐Induced Secondary Hypocorticism Manifesting as a Transitory Ischemic Attack
by: Josef Finsterer
Published: (2025)

Fatal Methaemoglobin Intoxication Following Ketamine Infusion in a Depressed MELAS Patient: A Possible Association?
by: Josef Finsterer
Published: (2025)

Pitfalls in Calculating the Incidence of Guillain‐Barre Syndrome During the Pandemic
by: Josef Finsterer
Published: (2025)

Are Insulin and Metformin Really Protective on Amyotrophic Lateral Sclerosis by Blocking the Astrocytic Cx43 Channel?
by: Josef Finsterer
Published: (2025)